Atıf Formatları
Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Karasu Et Al. , "Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy," CUTANEOUS AND OCULAR TOXICOLOGY , vol.41, no.2, pp.145-154, 2022

Karasu, B. Et Al. 2022. Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy. CUTANEOUS AND OCULAR TOXICOLOGY , vol.41, no.2 , 145-154.

Karasu, B., Akbas, Y. B., KAŞKAL, M., Aykut, A., & ÇELEBİ, A. R. C., (2022). Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy. CUTANEOUS AND OCULAR TOXICOLOGY , vol.41, no.2, 145-154.

Karasu, Bugra Et Al. "Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy," CUTANEOUS AND OCULAR TOXICOLOGY , vol.41, no.2, 145-154, 2022

Karasu, Bugra Et Al. "Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy." CUTANEOUS AND OCULAR TOXICOLOGY , vol.41, no.2, pp.145-154, 2022

Karasu, B. Et Al. (2022) . "Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy." CUTANEOUS AND OCULAR TOXICOLOGY , vol.41, no.2, pp.145-154.

@article{article, author={Bugra Karasu Et Al. }, title={Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy}, journal={CUTANEOUS AND OCULAR TOXICOLOGY}, year=2022, pages={145-154} }